Learning Catalog Advanced Search

Search by Category
Search by Format
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Speakers
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By

  • INS 2025 Virtual Conference
    Contains 21 Product(s)

    The INS 2025 Virtual Conference offers an excellent alternative for those unable to attend the in-person event. Participants can access 20 curated sessions virtually and on-demand, providing CRNI®s the opportunity to earn up to 40 recertification units (RUs). The virtual conference will feature sessions from the Vascular Access Device (VAD) Track, focusing on the critical role of vascular access devices in infusion therapy, the Alternative Care Setting Track, highlighting patient care beyond acute care environments, and the new Global Initiatives Track, focusing on infusion therapy initiatives in countries from all over the world.

    The INS 2025 Virtual Conference offers an excellent alternative for those unable to attend the in-person event. Participants can access 20 curated sessions virtually and on-demand, providing CRNI®s the opportunity to earn up to 40 recertification units (RUs).

    The virtual conference will feature sessions from the Vascular Access Device (VAD) Track, focusing on the critical role of vascular access devices in infusion therapy, the Alternative Care Setting Track, highlighting patient care beyond acute care environments, and the new Global Initiatives Track, focusing on infusion therapy initiatives in countries from all over the world.

  • Administration and Safety of Intravenous Iron
    Contains 3 Component(s), Includes Credits Includes a Live Web Event on 02/11/2025 at 1:00 PM (EST)

    Intravenous (IV) iron is a crucial treatment option for iron deficiency (ID) and iron deficiency anemia (IDA), especially in cases where oral iron supplements are insufficient, poorly tolerated, or ineffective. It is important for clinicians who are infusing IV iron to understand how to administer IV iron, assess and intervene if hypersensitivity reactions occur, and treat post-infusion hypophosphatemia. In this session, we will provide guidance on the administration of and classification of IV iron formulations, classification of, and management of infusion reactions and treatment-emergent hypophosphatemia.

    image

    Intravenous (IV) iron is a crucial treatment option for iron deficiency (ID) and iron deficiency anemia (IDA), especially in cases where oral iron supplements are insufficient, poorly tolerated, or ineffective. It is important for clinicians who are infusing IV iron to understand how to administer IV iron, assess and intervene if hypersensitivity reactions occur, and treat post-infusion hypophosphatemia. In this session, we will provide guidance on the administration of and classification of IV iron formulations, classification of, and management of infusion reactions and treatment-emergent hypophosphatemia.

    Learning Objectives: At the conclusion of this session, learners will be able to:
    • Know the intravenous iron formulations and their administration
    • Describe and recognize complement-mediated hypersensitivity reaction (CARPA) 
    • Discuss the management of hypersensitivity reactions to intravenous iron
    • Recognize formulations that lead to treatment-emergent hypophosphatemia and the populations most affected. 

    Layla Van Doren, MD, MBA

    Dr. Layla Van Doren, MD, MBA is an Assistant Professor of Medicine at Yale School of Medicine, where she specializes in classical hematology with an expertise in the diagnosis and management of iron- related disorders, including iron deficiency and anemia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: February 11, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Season 1 Episode 2: January 28, 2025 - Advancing Infusion Care in Poland
    Contains 0 Component(s)

    In this episode of the INS Infusion Room, host Derek Fox speaks with Dr. Maciej Latos about the advancements in infusion care and vascular access in Poland. Dr Latos shares his extensive experience in critical care nursing and the evolution of vascular access practices in Poland, particularly during the COVID-19 pandemic. The conversation highlights the importance of interdisciplinary collaboration, education, and the establishment of the Polish Society of Infusion Nursing. Dr Latos also discusses the challenges faced in implementing new practices, the significance of celebrating IV Nurse Day, and the future goals for infusion care in Poland.

    In this episode of the INS Infusion Room, host Derek Fox speaks with Dr. Maciej Latos about the advancements in infusion care and vascular access in Poland. Dr Latos shares his extensive experience in critical care nursing and the evolution of vascular access practices in Poland, particularly during the COVID-19 pandemic. The conversation highlights the importance of interdisciplinary collaboration, education, and the establishment of the Polish Society of Infusion Nursing. Dr Latos also discusses the challenges faced in implementing new practices, the significance of celebrating IV Nurse Day, and the future goals for infusion care in Poland.

    Maciej Latos, PhD, MSc

    Maciej Latos, PhD, MSc in nursing, is a specialist in anesthesia and intensive care nursing. He is also a paramedic involved in development infusion care and vascular access management in Poland. Dr Latos is an assistant in the Department of Anaesthesiology and Intensive Care Education at the Medical University of Warsaw. He is an instructor on vascular access courses: ultrasound-guided Midline and peripheral intravenous catheters (PIVCs). Dr Latos is involved with the implementation of good practice in nursing. He is President of the Board of Directors in the Polish Society of Infusion Nursing and Head of the Vascular Access and Infusion Team at the University Clinical Center of the Medical University of Warsaw. Dr Latos is Chair of the Safe Vascular Access Working Group of the Expert Council of the Hospital Safety Coalition and a member of the Polish Parliamentary Group on Health Professions. He is co-founder of Midline Academy: a platform for vascular access enthusiasts to share their experiences. Dr Latos is co-author of the book Vascular Access in Clinical Practice and Midline Catheters and Long Peripheral Catheters in Clinical Practice (in Polish). He is also a member of the Infusion Nurses Society.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC, Nurse Educator

    Guest: Dr. Maciej Latos 

    In this episode of the INS Infusion Room, host Derek Fox speaks with Dr. Maciej Latos about the advancements in infusion care and vascular access in Poland. Dr Latos shares his extensive experience in critical care nursing and the evolution of vascular access practices in Poland, particularly during the COVID-19 pandemic. The conversation highlights the importance of interdisciplinary collaboration, education, and the establishment of the Polish Society of Infusion Nursing. Dr Latos also discusses the challenges faced in implementing new practices, the significance of celebrating IV Nurse Day, and the future goals for infusion care in Poland.

  • The Role of the Nurse in the Use of Intraosseous Vascular Access Devices
    Contains 1 Component(s)

    The Emergency Nurses Association (ENA), Infusion Nurses Society (INS), American Heart Association, American College of Emergency Physicians, American College of Surgeons, European Resuscitation Council, the National Association of Emergency Medical Services Physicians, American Association of Critical-Care Nurses, and many other authoritative bodies recommend intraosseous vascular access devices as an option to reduce the time to first drug and fluid administration in resuscitation situations. This joint position statement by INS and ENA updates and replaces the supported 2019 INS Position Paper, The Role of the Registered Nurse in the Insertion of Intraosseous Access Devices. [Approved December 2024]

    The Emergency Nurses Association (ENA), Infusion Nurses Society (INS), American Heart Association, American College of Emergency Physicians, American College of Surgeons, European Resuscitation Council, the National Association of Emergency Medical Services Physicians, American Association of Critical-Care Nurses, and many other authoritative bodies recommend intraosseous vascular access devices as an option to reduce the time to first drug and fluid administration in resuscitation situations. This joint position statement by INS and ENA updates and replaces the supported 2019 INS Position Paper, The Role of the Registered Nurse in the Insertion of Intraosseous Access Devices.

    approved December 2024

  • Integrating Patient- and Family-Centered Care in Vascular Access Management
    Contains 3 Component(s), Includes Credits Recorded On: 01/15/2025

    This session explores the principles of Patient- and Family-Centered Care (PFCC) through the compelling story of an individual living with Short Bowel Syndrome (SBS) since birth, requiring long-term vascular access for 35 years. Audience members will gain insight on strategies to enhance patient and family centered care for individuals living with chronic vascular access needs in their patient settings. This session will highlight patient experiences, health care delivery challenges, and barriers to accessing appropriate and timely care. There will be a focus on resources, language to use, and actions to take to promote collaborative and compassionate delivery of care.

    This session explores the principles of Patient- and Family-Centered Care (PFCC) through the compelling story of an individual living with Short Bowel Syndrome (SBS) since birth, requiring long-term vascular access for 35 years. Audience members will gain insight on strategies to enhance patient and family centered care for individuals living with chronic vascular access needs in their patient settings. This session will highlight patient experiences, health care delivery challenges, and barriers to accessing appropriate and timely care. There will be a focus on resources, language to use, and actions to take to promote collaborative and compassionate delivery of care.

    Learning Objectives: At the conclusion of this session, learners will be able to: 

    • Learn an example of the rare gastrointestinal (GI) chronic disease journey
    • Explain Patient- and Family-Centered Care (PFCC)
    • Describe the challenges and gaps in requiring long-term vascular access
    • Discuss strategies to implement a patient and family-centered approach in current care routine
    • Illustrate the mechanisms behind successful partnerships between patient/family and clinical care providers 

    Swapna Kakani, MPH

    Swapna Kakani, MPH, is an advocate, speaker, consultant, and researcher in rare and chronic disease health care delivery and patient experience. Through her platform, Swapna Speaks, Swapna has spoken across the world to various companies and associations and has given a TEDx talk. Swapna also does health care advocacy, research, and policy work for the intestinal failure, vascular access, and broader rare disease communities in her home state of Alabama and nationally. In 2017, she founded Alabama Rare, an organization advancing health care policy and education for Alabama’s rare disease community. In 2021, she, alongside parent researchers/advocates, co-founded the gutsy perspective, a research initiative driven by members of the short bowel syndrome community to ensure the patient and family narrative is represented in research and patient-centered outcomes. Swapna was born with short bowel syndrome and has lived with a combination of total parenteral nutrition (TPN), IV fluids, tube feeding, and an ostomy for 35 years. She received a small intestine transplant 10 years ago. Swapna resides in Huntsville, AL, and received her Master's degree in Public Health at the University of Alabama at Birmingham.

    Swapna Kakani, MPH (she/her/hers)
    Advocate - Speaker - Consultant - Researcher
    E: info@swapnakakani.com
    W Consultant: www.SwapnaKakani.com
    W Researcher: community-driven research on life with SBS | the gutsy perspective
    W Policy Action: www.alabamarare.org

    imageimageimageimage

    image

    the gutsy perspective
    thegutsyperspective.org 

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: January 15, 2028

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Season 1 Episode 1: January 14, 2025 - Passing the Baton
    Contains 2 Component(s)

    Dawn Berndt announces her retirement and introduces a new host for the INS Infusion Room. Dawn reflects over her career, time served at INS, and her experiences as the podcast host. She offers words of wisdom and opens dialogue regarding the future of the podcast, including some new upgrades and changes with the relaunch.

    Dawn Berndt announces her retirement and introduces a new host for the INS Infusion Room. Dawn reflects over her career, time served at INS, and her experiences as the podcast host. She offers words of wisdom and opens dialogue regarding the future of the podcast, including some new upgrades and changes with the relaunch.

    Dawn Berndt, DNP, RN, CRNI®

    Dawn Berndt, DNP, RN, CRNI® serves as the INS Clinical Education and Publications Manager. She has been an active INS member and a CRNI® since 2005. Dr. Berndt served on INS’ National Council on Education and on the INS board of directors as a director-at-large from 2017 to 2018. Prior to joining the INS team, she worked for 13 years as a clinical nurse specialist for infusion and as nurse manager of the infusion center, the venous access team, and the RN response team at the University of Wisconsin Hospital and Clinics. Dr. Berndt holds a doctor of nursing practice in clinical leadership from the Henry Predolin School of Nursing at Edgewood College in Madison, Wisconsin and a master’s of nursing education from the University of Wisconsin School of Nursing.

    Host: Derek Fox, MSN, RN, VA-BC, CRNI®, NEA-BC, Nurse Educator

    Guest: Dawn Berndt, DNP, RN, CRNI®, Editor-in-Chief, Journal of Infusion Nursing

    Dawn Berndt announces her retirement and introduces a new host for the INS Infusion Room. Dawn Reflects over her career, time served at INS, and her experiences as the podcast host. She offers words of wisdom and opens dialogue regarding the future of the podcast, including some new upgrades and changes with the relaunch.

  • INS Guidance to Address IV Solution Shortages as a Result of Hurricane Helene
    Contains 1 Component(s)

    Due to extensive damage sustained by Baxter’s North Cove, NC, facility from Hurricane Helene, INS has issued the following guidance, based on the 2024 Infusion Therapy Standards of Practice. INS is dedicated to assisting health care providers in managing product shortages while maintaining high standards of care.

    Due to extensive damage sustained by Baxter’s North Cove, NC, facility from Hurricane Helene, INS has issued the following guidance, based on the 2024 Infusion Therapy Standards of Practice. INS is dedicated to assisting health care providers in managing product shortages while maintaining high standards of care.

    2024

  • Exploration of the Current State of PIVC Placement and Complications: Clinical Implications
    Contains 3 Component(s), Includes Credits Recorded On: 11/20/2024

    This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.

    This session will provide an overview of findings gleaned from a point prevalence study on PIVC placement and complications. Details regarding the study process and associated findings will be provided. Lessons learned and education and practice implications will also be explored.

    Learning Objectives: At the conclusion of this session, learners will be able to: 
    ● Describe the process for a point prevalence study
    ● Discuss common findings gleaned from the point prevalence study
    ● Identify recommended practices to improve PIVC documentation and complication recognition

    Judy Smith, MSN, RN, CRNI®

    Judy Smith, MSN, RN, CRNI®, serves as Director of Vascular Access and Wound Care for Ascension Seton in Austin, Texas. She completed her BSN at the University of Texas at Austin in 1995 and her MSN in Healthcare Systems Management at Loyola University New Orleans in 2010. She has worked in the Vascular Access specialty for 21 years and published 2 research studies on disinfection of needleless connectors and 1 point prevalence study related to PIVC complications and documentation. She has presented at many Vascular Access and Infusion Therapy conferences in the United States and New Zealand. Judy enjoys reading and spending time with her family, especially her 2 grandsons.

    Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN

    Vallire Hooper, PhD, RN, CPAN, FASPAN, FAAN, is a Senior Nurse Scientist with Ascension. She has been a nurse for over 35 years, with a primary focus in perianesthesia nursing, working as a staff nurse, Clinical Nurse Specialist, and lastly, as a Clinical Nurse Scientist for the last 14 years. Dr Hooper obtained her PhD in Nursing from the Medical College of Georgia in 2009, with a research focus on factors influencing the multidisciplinary adoption of evidence-based clinical practice guidelines. She is a Fellow in the American Society of PeriAnesthesia Nurses as well as the American Academy of Nursing. Dr Hooper’s primary research interests include clinically focused patient outcomes research and factors influencing nursing care delivery.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: November 20, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.

  • Extravasation Prevention Checklist
    Contains 1 Component(s)

    In 2017, INS formed a Vesicant Task Force (VTF) with the goal to formulate an evidence-based list of noncytotoxic vesicant medications and solutions. At the conclusion of that work, the VTF recommended that the list be updated on a regular basis as new data emerge and as new medications are introduced into the market. So, in 2021, a new VTF was formed to review the literature and revise the 2017 vesicant list. Recognition of vesicants and their relative risk of injury is essential to extravasation prevention, early recognition, and appropriate treatment. To this end, the VTF developed and published an updated Extravasation Prevention Checklist in 2024. We are pleased to share this updated Extravasation Prevention Checklist in the INS Learning Center. To access the checklist, click "Register" and log in. Then, you can download the official document.

    In 2017, INS formed a Vesicant Task Force (VTF) with the goal to formulate an evidence-based list of noncytotoxic vesicant medications and solutions. At the conclusion of that work, the VTF recommended that the list be updated on a regular basis as new data emerge and as new medications are introduced into the market. So, in 2021, a new VTF was formed to review the literature and revise the 2017 vesicant list. Recognition of vesicants and their relative risk of injury is essential to extravasation prevention, early recognition, and appropriate treatment. To this end, the VTF developed and published an updated Extravasation Prevention Checklist in 2024. We are pleased to share this updated Extravasation Prevention Checklist in the INS Learning Center.

    To access the checklist, click "Register" and log in. Then, you can download the official document.

    To access the complete article in the Journal of Infusion Nursing:

    https://journals.lww.com/journ...

  • Extravasation Treatment: A Case Study Approach to Explore Options
    Contains 3 Component(s), Includes Credits Recorded On: 09/18/2024

    The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.

    The treatment of an extravasation, the inadvertent delivery of a vesicant into the tissue around a vascular access device (VAD), is a source of patient harm that is under-recognized, under-reported, and thus likely ineffectively treated. Unfortunately, recommendations for extravasation treatment (primarily reliant on case reports) can be difficult to leverage into clear clinical guidelines, increasing the risk of inadequate or delayed post-extravasation monitoring and treatment. This presentation will review vesicant properties and their mechanisms of tissue injury, peripheral vs central VAD extravasation risks with related prevention measures, and recommended extravasation treatment strategies and resources using a case study approach.

    Objectives:

    • Describe the properties of the major vesicant categories that may precipitate tissue injury
    • Relate the relative extravasation risks of peripheral vs central VADS to extravasation prevention strategies
    • Describe current recommendations for treatment of selected vesicant extravasations, using a case study approach

    Barb Nickel, APRN-CNS, CCRN, CRNI®

    Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel was a co-author of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, was Chair of the 2024 9th edition of the INS Standards of Practice Committee and is chair of the 2027 INS Standards Committee. She has authored several publications and speaks nationally on optimization of infusion therapy outcomes. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

    CRNI® RUs: This session has been approved for 2 CRNI® recertification units and meets the non INS Meeting criteria.

    Contact Hours: This session has been approved for 1 contact hour

    Expiration date for receipt of contact hours: September 18, 2027

    To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.

    The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.